Document is current
Any future updates will be listed below
-
Authors
Wang, Zhen https://orcid.org/0009-0008-5083-1853
Li, Zhixin
Högström, Jenny https://orcid.org/0000-0001-5932-0146
Inuzuka, Hiroyuki
Jing, Rui
Yan, Peiqiang
Hou, Tao
Qi, Yihang https://orcid.org/0000-0001-7589-0333
Huang, Daoyuan
Wang, Jingchao
Wu, Ting
Shi, Xiaoying https://orcid.org/0009-0003-0643-6841
Liu, Bolin https://orcid.org/0000-0003-0150-8650
Muranen, Taru https://orcid.org/0000-0003-4158-9002
Zhang, Dingpeng https://orcid.org/0000-0001-9652-0067
Wei, Wenyi https://orcid.org/0000-0003-0512-3811
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA253027)
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 26 August 2025
First Online: 2 October 2025
Competing interests
: W.W. is a co-founder and stockholder of Rekindle Therapeutics. All other authors declare no competing interests.
